The Usefulness of Integrated PET/CT to Distinguish between Benignancy and Malignancy in Solitary Pulmonary Nodule.
10.12701/yujm.2006.23.2.205
- Author:
Won Jong PARK
1
;
Dong Hee KIM
;
Sung Ken YU
;
Kyeong Cheol SHIN
;
Jin Hong CHUNG
;
Kwan Ho LEE
;
Kyung Ah CHUN
;
Ihn Ho CHO
Author Information
1. Department of Internal Medicine, College of Medicine, Yeungnam University, Daegu, Korea. jhchn@med.yu.ac.kr
- Publication Type:Original Article
- Keywords:
PET/CT;
Solitary pulmonary nodule;
Standardized uptake value
- MeSH:
Biopsy;
Humans;
Positron-Emission Tomography and Computed Tomography*;
Solitary Pulmonary Nodule*
- From:Yeungnam University Journal of Medicine
2006;23(2):205-212
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
BACKGROUND: Malignant pulmonary nodules account for about 30 to 40 percent of solitary pulmonary nodules (SPN). Therefore, tissue characterization of SPNs is very important. Recently, PET/CT has been widely used for tissue characterization, and has become of importance. The purpose of this study was to compare and to assess multiple factors in PET/CT comparing benign and malignant nodules. MATERIALS AND METHOD: Nineteen patients with SPN underwent PET/CT and biopsy. The difference of standardized uptake value 1 (SUV1), standardized uptake value 2 (SUV2) and retention index in PET/CT between malignancy and benignancy were compared by Levene's test. RESULT: There were twelve malignant and seven benign nodules. SUV1 and SUV2 were significantly different between malignant nodule and benign nodule (p=0.006 and 0.022), but retention index was not significantly different between malignant nodule and benign nodule (p=0.526). By receiver-operating-characteristic (ROC) analysis, the sensitivity was 66.7% and the specificity was 71.4% at a cut off value of 5.40 in SUV1. The sensitivity was 75% and the specificity was 71.4% at cut off value of 7.45 in SUV2. CONCLUSION: There was a statistically significant difference in SUV1 and SUV2 between benign and malignant nodules. However, the cut off value of SUV1 and SUV2 by receiver-operating-characteristic (ROC) analysis was 5.40 and 7.45 which is different from previous studies. Therefore, studies on a larger sample of patients are required for confirmation.
